Antipsychotic use in nursing homes varies by psychiatric consultant
- PMID: 24374410
- PMCID: PMC3948216
- DOI: 10.1097/MLR.0000000000000076
Antipsychotic use in nursing homes varies by psychiatric consultant
Abstract
Background: The relationship between psychiatric consultation and antipsychotic prescribing in nursing homes (NH) is unknown.
Objective: To identify the association between psychiatric consultant groups and NH-level antipsychotic prescribing after adjustment for resident case-mix and facility characteristics.
Research design and subjects: Nested cross-sectional study of 60 NHs in a cluster randomized trial. We linked facility leadership surveys to October 2009-September 2010 Minimum Data Set, Nursing Home Compare, the US Census, and pharmacy dispensing data.
Measures: The main exposure is the psychiatric consultant group and the main outcome is NH-level prevalence of atypical antipsychotic use. We calculated annual means and interquartile ranges of NH-level antipsychotic use for each consultant group and arrayed consultant groups from lowest to highest prevalence. Generalized linear models were used to predict antipsychotic prescribing adjusting for resident case-mix and facility characteristics. Observed versus predicted antipsychotic prescribing levels were compared for each consultant group.
Results: Seven psychiatric consultant groups served a range of 3-27 study facilities. Overall mean facility-level antipsychotic prescribing was 19.2%. Mean prevalence of antipsychotic prescribing ranged from 12.2% (SD, 5.8) in the lowest consultant group to 26.4% (SD, 3.6) in the highest group. All facilities served by the highest-ranked consultant group had observed antipsychotic levels exceeding the overall study mean with half exceeding predictions for on-label indications, whereas most facilities served by the lowest-ranked consultant group had observed levels below the overall study and predicted means.
Conclusions: Preliminary evidence suggests that psychiatric consultant groups affect NH antipsychotic prescribing independent of resident case-mix and facility characteristics.
Figures
Similar articles
-
Use of atypical antipsychotics in nursing homes and pharmaceutical marketing.J Am Geriatr Soc. 2015 Feb;63(2):297-301. doi: 10.1111/jgs.13180. J Am Geriatr Soc. 2015. PMID: 25688605 Free PMC article. Clinical Trial.
-
Association of a Communication Training Program With Use of Antipsychotics in Nursing Homes.JAMA Intern Med. 2017 Jun 1;177(6):846-853. doi: 10.1001/jamainternmed.2017.0746. JAMA Intern Med. 2017. PMID: 28418449 Free PMC article.
-
Variability between nursing homes in prevalence of antipsychotic use in patients with dementia.Int Psychogeriatr. 2014 Mar;26(3):363-71. doi: 10.1017/S1041610213002019. Epub 2013 Nov 20. Int Psychogeriatr. 2014. PMID: 24252349
-
Challenge of changing nursing home prescribing culture.Am J Geriatr Pharmacother. 2012 Feb;10(1):37-46. doi: 10.1016/j.amjopharm.2011.12.005. Epub 2012 Jan 20. Am J Geriatr Pharmacother. 2012. PMID: 22264855 Free PMC article. Review.
-
Factors Associated with Potentially Harmful Medication Prescribing in Nursing Homes: A Scoping Review.J Am Med Dir Assoc. 2022 Sep;23(9):1589.e1-1589.e10. doi: 10.1016/j.jamda.2022.06.008. Epub 2022 Jul 20. J Am Med Dir Assoc. 2022. PMID: 35868350 Free PMC article.
Cited by
-
Effectiveness of confidential reports to physicians on their prescribing of antipsychotic medications in nursing homes.Implement Sci Commun. 2020 Feb 25;1:30. doi: 10.1186/s43058-020-00013-9. eCollection 2020. Implement Sci Commun. 2020. PMID: 32885189 Free PMC article.
-
Improving the appropriateness of antipsychotic prescribing in nursing homes: a mixed-methods process evaluation of an academic detailing intervention.Implement Sci. 2017 May 26;12(1):71. doi: 10.1186/s13012-017-0602-z. Implement Sci. 2017. PMID: 28549480 Free PMC article.
-
Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review.BMC Geriatr. 2017 Jan 26;17(1):32. doi: 10.1186/s12877-017-0428-1. BMC Geriatr. 2017. PMID: 28122506 Free PMC article.
-
Use of atypical antipsychotics in nursing homes and pharmaceutical marketing.J Am Geriatr Soc. 2015 Feb;63(2):297-301. doi: 10.1111/jgs.13180. J Am Geriatr Soc. 2015. PMID: 25688605 Free PMC article. Clinical Trial.
-
Antipsychotics and dementia in Canada: a retrospective cross-sectional study of four health sectors.BMC Geriatr. 2017 Oct 23;17(1):244. doi: 10.1186/s12877-017-0636-8. BMC Geriatr. 2017. PMID: 29061129 Free PMC article.
References
-
- Health Care Financing Administration. Medicare and Medicaid: requirements for long-term care facilities, final regulations. Federal Register. 1991 Sep 26;56:48865–48921.
-
- Fenton J, Raskin A, Gruber-Baldini AL, et al. Some predictors of psychiatric consultation in nursing home residents. Am J Geriatr Psychiatry. 2004;12:297–304. - PubMed
-
- Streim JE, Beckwith EW, Arapakos D, et al. Mental health services in nursing homes: Regulatory oversight, payment policy, and quality improvement in mental health care in nursing homes. Psych Serv. 2002;53:1414–1418. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical